In September 2021, Cell and Gene Therapy Manufacturing & Commercialization US returned for the first time as a hybrid conference.
Co-located with BioProcess International, the event spanned across seven days, welcoming audiences in Boston and online, with tracks exploring:
- Cell Therapy
- Gene Edited Ex Vivo Cell Therapy
- In Vivo Gene Therapy
- Partnering & Collaborations
- Tissue Engineering
In this post-event report in association with Avantor, we gather a collection of highlights from the week, including top presentations, a key panel discussion, poster and a spotlight session to watch on demand.
Click the image below or here to explore the report, or download a PDF version using the 'Download Now' link at the top of the page.